XML 158 R13.htm IDEA: XBRL DOCUMENT
v3.25.2

Investment in Financial Assets | 12 Months Ended
--- | ---
Dec. 31, 2024
Investment in Financial Assets [Abstract] |
INVESTMENT IN FINANCIAL ASSETS |
NOTE 8:- | INVESTMENT IN FINANCIAL ASSETS
|  | Clearmind On November 17, 2022, the Company invested $1,500 in the initial public offering of Clearmind Medicine Inc. (“Clearmind”) and received 230,769 common shares of Clearmind, resulting in the Company holding 9.33% of share capital of Clearmind. Shares of Clearmind are listed for trading on Nasdaq Capital Market and the Canadian Securities Exchange under the symbol “CMND” and the Frankfurt Stock Exchange under the symbol “CWY.” On November 21, 2023, Clearmind conducted a reverse share split of its issued and outstanding ordinary shares, no par value, at a ratio of 1-for-30. As a result, the Company holdings in Clearmind decreased from 230,769 common shares to 7,692. As of December 31, 2024, the listed share price of Clearmind on Nasdaq was $1.38 and the Company has recorded a loss in its statements of comprehensive loss for the year ended December 31, 2024 of $11 on its investment (for the year ended December 31, 2023 - $727).

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfFinancialAssetsAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the investment financial assets. + References No definition available. + Details
Name: | sprcy_DisclosureOfInvestmentFinancialAssetsExplanatory
Namespace Prefix: | sprcy_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration